State Street SPDR S&P Pharmaceuticals ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.35
資產淨值: 55.73
成立日期: 19/06/2006
 
分析
市值分佈:
40.84%
大市值
43.53%
中市值
14.07%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 59  
0%
 
100%
     10大 (23.32%)
代號 名稱 佔比% 持有日期
DFTXDefinium Therapeutics Inc2.6127/02/2026
VTRSViatris2.3927/02/2026
EWTXEdgewise Therapeutics2.3827/02/2026
PAHCPhibro Animal Health Corp2.3527/02/2026
MRKMerck & Co2.3527/02/2026
ELANElanco Animal Health2.3027/02/2026
BMYBristol-Myers Squibb Co2.2627/02/2026
RPRXRoyalty Pharma plc2.2427/02/2026
JNJJohnson & Johnson2.2327/02/2026
NKTRNektar Therapeutics2.2127/02/2026
SUPNSupernus Pharmaceuticals2.2027/02/2026
JAZZJazz Pharmaceuticals plc2.1427/02/2026
AMLXAmylyx Pharmaceuticals2.1327/02/2026
AMRXAmneal Pharmaceuticals2.1027/02/2026
MBXMBX Biosciences Inc.2.0927/02/2026
PBHPrestige Consumer Healthcare2.0927/02/2026
ELVNEnliven Therapeutics2.0827/02/2026
INVAInnoviva2.0627/02/2026
ZTSZOETIS2.0627/02/2026
AXSMAxsome Therapeutics2.0427/02/2026
 1    2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.